Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint.
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 200 points on Monday. Here are some big stocks recording losses in today’s session.
An official claimed that the United States would withdraw a 17-month-old rule that people arriving in the country by air test negative for COVID-19, a move that comes after strong lobbying by airlines and the travel industry,
China Eastern Airlines Corp (NYSE: CEA) resumed passenger flights of its Boeing Co (NYSE: BA) 737-800 model aircraft after grounding the planes for nearly a month